简介 :HQL-79, a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.
Catalog_No:HY-108259
Alternative_Names:
产品一级分类:信号通路
二级分类:生命科学试剂
SMILES:N1(CCCC2=NN=NN2)CCC(OC(C3=CC=CC=C3)C4=CC=CC=C4)CC1
Pathway:Immunology/Inflammation
Target:PGE synthase
Research_Area:Inflammation/Immunology
国际站:HQL-79